Monkeypox (MPOX) Vaccine

sms-icon

Text COSD MONKEYPOX to 468-311.

Get text updates about MPOX from the County. Text COSD MONKEYPOX to 468-311. (Phone users: tap to create the message)

MPOX Vaccine

Schedule your MPOX Jynneos Vaccine! Appointments are available at MyTurn.ca.gov.

Click here for a list of County coordinated vaccination sites

MPOX VACCINE ELIGIBILITY

MPOX vaccine is now available to the following groups:

  • Gay or bisexual men, or any men or transgender people who have sex with men or transgender people.
  • Persons of any gender or sexual orientation who engage in commercial and/or transactional sex (e.g., sex in exchange for money, shelter, food, or other goods or needs)
  • Persons living with HIV, especially persons with uncontrolled or advanced HIV disease.
  • Persons who had skin-to-skin or intimate contact with someone with suspected or confirmed monkeypox, including those who have not yet been confirmed by Public Health.

The following is a list of County-coordinated vaccination sites. Please visit the MPOX Vaccinations Schedule webpage for more information.

  • Balboa Park Golden Hill Community Clubhouse (San Diego)^ 
    • 2464 Russ Blvd, San Diego, CA 92102
  • East Public Health Center (El Cajon)* 
    • 367 N. Magnolia Ave, 92020 
  • North Central Public Health Center (San Diego)* 
    • 5055 Ruffin Rd., 92123
  • North Coastal Live Well Health Center (Oceanside)* 
    • 1701 Mission Ave., Oceanside, CA 92058 
  • North Inland Public Health Center (Escondido)* 
    • 649 W. Mission Ave, 92025 

Point of Dispensing (POD) County Regional Sites
^ POD Community Sites

 VACCINE-RELATED FREQUENTLY ASKED QUESTIONS

Expand All | Collapse All

  • Where can I get vaccinated?

    Eligible individuals may book an appointment at www.MyTurn.ca.gov or through their healthcare provider. Additionally, please visit the MPOX Vaccinations Schedule webpage for a list of County-coordinated vaccination sites.

  • How can I schedule my second dose of MPOX vaccine?

    Eligible individuals may book an appointment at www.MyTurn.ca.gov or through their healthcare provider.

    Please continue to check our website, at www.sandiegocounty.gov/monkeypoxsd, and sign up for text alerts by texting COSD Monkeypox to 468-311, for updated information about vaccine availability.

  • If I had the smallpox vaccine, am I protected from MPOX?
    • MPOX and smallpox are in the same family of viruses. 
    • According to the CDC, since MPOX is closely related to the virus that causes smallpox, the smallpox vaccine can protect you from getting MPOX.

    However, if you have been exposed to MPOX and it has been three years or more since your smallpox vaccine, you should obtain the MPOX vaccine. The Jynneos vaccine has been FDA-approved for MPOX.

  • How are vaccine doses allocated to local health jurisdictions (LHJ) in California?

    The CDPH allocates a certain number of doses per LHJ, based on certain criteria, which are used to distribute the limited number of MPOX vaccines to LHJs. To determine populations at highest risk of MPOX transmission, the criteria include the number of MPOX cases and early syphilis cases among men, as a proxy. The County of San Diego does not determine these criteria.

    Given the continued limited supply of the Jynneos vaccine, the County of San Diego will provide first doses to offer protection to more at-risk San Diegans. This is the best strategy until an adequate vaccine supply is received. Additionally, this single dose strategy is consistent with the MPOX vaccine distribution strategy taken in the California Department of Public Health, New York, United Kingdom (UK), and Canada.

    See "How can I schedule my second dose of MPOX vaccine?" question above.

     

WHAT YOU NEED TO KNOW

  • JYNNEOS vaccine is approved for the prevention of MPOX and smallpox disease.
  • The standard regimen for JYNNEOS involves a subcutaneous (SQ) route of administration with an injection volume of 0.5mL. In the context of the current national Public Health Emergency (PHE), an alternative regimen involving intradermal (ID) administration with an injection volume of 0.1mL may be used under an Emergency Use Authorization (EUA).
  • People can be vaccinated after exposure to MPOX virus to help prevent MPOX disease (i.e., post-exposure prophylaxis).
  • No data are currently available on the clinical efficacy or effectiveness of JYNNEOS vaccines in the current outbreak.
  • Because there are limitations in our knowledge about the effectiveness of these vaccines in the current outbreak, people who are vaccinated should continue to take steps to protect themselves from infection by avoiding close, skin-to-skin contact, including intimate contact, with someone who has MPOX.
  • Globally and in the United States, supply of JYNNEOS vaccine is currently limited, although more is expected in the coming weeks and months. In the United States, there is a large supply of ACAM2000, but this vaccine has more side effects and contraindications. Hence, it will not be used by the Centers for Disease Control and Prevention (CDC). 
  • For more information:

VACCINATION SCHEDULE AND DOSING REGIMENS FOR JYNNEOS VACCINE1

Regimen

Route of Administration

Injection
Volume

Recommended
number of Doses

Recommended Interval between
1st and 2nd Dose

Alternative Regimen

People age ≥18 years

Intradermal

0.1 mL

2

28 days

Standard Regimen

People age <18 years

Subcutaneous

0.5 mL

2

28 days

People of any age with history of developing keloid formation

Subcutaneous

0.5 mL

2

28 days

CUMULATIVE VACCINE SUMMARY
Updated Weekly (Tuesday)
Data Through 10/3/2022

Note: Effective 8/29/22, the Cumulative Vaccine Summary will be updated on Tuesdays, with data through the previous day.

Data are preliminary and subject to change

Grey Arrow

35,608 vials requested by the County.

bluearrow

10,057 vials received by the County.1

orangearrow

7,785 vials allocated/distributed^

greenarrow

2,272 vials reserved for post-exposure prophylaxis. 

The number of vials received was allocated from the California Department of Public Health (CDPH) to respond to the current MPOX outbreak. These vials are then distributed to public and community/hospital vaccination sites to administer.

^The number of vials distributed to healthcare systems, FQHC, and County clinics.

Data as of: October 3, 2022
Updated: October 4, 2022

MPOX (Jynneos) Vaccine Vial Allocation by Phase

Vaccination site locations are subject to change and do not imply vaccine availability, as most vaccine has been exhausted:

Note: Effective 8/29/22, the MPOX (Jynneos) Vaccine Vial Allocation by Phase will be updated on Tuesdays, with data through the previous day.

*Phases are determined by the California Department of Public Health (CDPH). Only vials allocated/re-allocated across the listed Phases are presented (not vials that were not administered).
^The number of vials re-distributed from North Coastal PHC and North Inland PHC for initial allocation to FHCSD.
^^The number of vials re-distributed from North Coastal STD Clinic to North Coastal PHC.
^^^The number of vials re-distributed from County Clinics to the Regional Evening Clinics.

Data as of: October 4, 2022
Updated: October 4, 2022

MPOX Vaccination Summary

Data are preliminary and subject to change

The MPOX Vaccinations Summary will be updated on Tuesdays, with data through the previous day.

San Diego County Residents Vaccinated with at Least One Dose of Jynneos Vaccine

11,087

Data as of October 03, 2022
 

Data as of: October 3, 2022
Updated: October 4, 2022

For more information, contact the Epidemiology Unit at (619) 692-8499 or send us an e-mail.